Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2019 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
STOK on Nasdaq
Shares outstanding
57,529,259
Price per share
$29.40
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
66,979,210
Total reported value
$2,125,914,751
% of total 13F portfolios
0%
Share change
+1,536,436
Value change
+$58,218,861
Number of holders
182
Price from insider filings
$29.40
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 9.8% -21% $177,773,201 -$40,123,708 5,600,920 -18% FMR LLC 31 Dec 2025
RTW INVESTMENTS, LP 10% $50,498,414 5,310,033 RTW Investments, LP 31 Dec 2024
Redmile Group, LLC 8% $52,554,931 4,375,931 Redmile Group, LLC 30 Jun 2025
BlackRock, Inc. 6.8% +17% $87,769,558 +$14,428,761 3,732,540 +20% BlackRock, Inc. 30 Sep 2025
MORGAN STANLEY 6.5% $32,588,288 3,426,739 Morgan Stanley 31 Dec 2024
BAKER BROS. ADVISORS LP 5.8% $105,906,763 3,336,697 Baker Bros. Advisors LP 31 Dec 2025
TORONTO DOMINION BANK 5.8% $74,571,563 3,173,258 The Toronto-Dominion Bank 30 Sep 2025
BlackRock Portfolio Management LLC 4.7% -8% $28,946,115 -$2,192,358 2,550,341 -7% BlackRock Portfolio Management LLC 30 Jun 2025
Skorpios Trust 4.1% -32% $29,037,049 -$12,870,000 2,256,181 -31% Montrago Trustees Ltd 22 Aug 2025

As of 31 Dec 2025, 182 institutional investors reported holding 66,979,210 shares of Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK). This represents 116% of the company’s total 57,529,259 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK) together control 103% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 9.7% 5,600,920 -18% 0.01% $177,773,201
RTW INVESTMENTS, LP 9.6% 5,546,856 +8.3% 1.8% $176,057,209
Lynx1 Capital Management LP 9.4% 5,404,674 0% 35% $171,544,353
BlackRock, Inc. 9.1% 5,212,554 -13% 0% $165,446,463
Redmile Group, LLC 7% 4,034,070 -3.4% 9.4% $128,041,382
MORGAN STANLEY 6.2% 3,546,158 +0.26% 0.01% $112,555,054
BAKER BROS. ADVISORS LP 5.8% 3,336,697 -28% 0.62% $105,906,763
TORONTO DOMINION BANK 5.5% 3,173,258 0% 0.18% $100,719,209
VANGUARD GROUP INC 5.5% 3,149,239 -0.46% 0% $99,956,846
STATE STREET CORP 4.3% 2,498,049 +75% 0% $79,288,075
BVF INC/IL 3.9% 2,265,674 +37% 2.4% $71,912,493
Siren, L.L.C. 3.9% 2,247,347 0% 2.1% $71,330,794
DEERFIELD MANAGEMENT COMPANY, L.P. 3.2% 1,823,500 0.74% $57,877,890
JANUS HENDERSON GROUP PLC 2.5% 1,450,933 +334% 0.02% $46,031,447
Polar Capital Holdings Plc 2.2% 1,269,131 -4.1% 0.18% $40,282,218
Assenagon Asset Management S.A. 2.1% 1,227,723 +36% 0.06% $38,967,928
Point72 Asset Management, L.P. 2.1% 1,222,213 -6.5% 0.06% $38,793,041
GEODE CAPITAL MANAGEMENT, LLC 2% 1,166,145 +1.7% 0% $37,019,868
GOLDMAN SACHS GROUP INC 2% 1,142,737 -0.71% 0.01% $36,270,472
DIMENSIONAL FUND ADVISORS LP 1.4% 827,139 +22% 0.01% $26,253,770
MPM BIOIMPACT LLC 1.3% 770,289 -2.5% 2.8% $24,448,973
WELLINGTON MANAGEMENT GROUP LLP 1.3% 735,799 -0.26% 0% $23,354,261
Opaleye Management Inc. 1.2% 695,000 +1.9% 2.9% $22,059,300
TANG CAPITAL MANAGEMENT LLC 0.87% 500,000 0% 0.78% $15,870,000
Candriam S.C.A. 0.78% 446,690 0.07% $14,178,544

Institutional Holders of Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 66,979,210 $2,125,914,751 +$58,218,861 $31.74 182
2025 Q3 67,691,438 $1,574,062,054 +$64,325,425 $23.50 151
2025 Q2 65,548,147 $743,993,162 +$30,166,679 $11.35 133
2025 Q1 63,384,229 $421,575,155 +$30,343,505 $6.65 124
2024 Q4 58,062,255 $640,428,361 -$5,638,079 $11.03 129
2024 Q3 58,214,468 $715,466,637 -$45,762,031 $12.29 116
2024 Q2 61,301,002 $828,175,296 +$96,412,204 $13.51 114
2024 Q1 54,138,461 $730,867,238 +$123,726,512 $13.50 101
2023 Q4 45,032,645 $236,869,874 +$6,784,370 $5.26 81
2023 Q3 43,943,299 $173,133,829 -$18,481,683 $3.94 96
2023 Q2 46,534,137 $494,657,865 +$21,008,744 $10.63 98
2023 Q1 44,636,031 $371,816,808 +$35,289,257 $8.33 97
2022 Q4 40,284,847 $371,831,189 -$22,554,117 $9.23 106
2022 Q3 42,272,703 $544,351,939 -$11,748,534 $12.84 99
2022 Q2 43,072,954 $569,403,611 +$19,595,358 $13.21 88
2022 Q1 41,334,322 $870,301,369 +$123,934,287 $21.05 96
2021 Q4 35,383,061 $848,561,802 +$26,332,046 $23.99 91
2021 Q3 19,355,184 $492,398,465 -$30,803,526 $25.44 89
2021 Q2 20,216,239 $680,314,450 -$703,085,149 $33.66 96
2021 Q1 38,422,385 $1,492,282,987 -$15,747,693 $38.84 104
2020 Q4 38,644,696 $2,393,196,414 +$252,468,837 $61.93 93
2020 Q3 34,632,372 $1,159,842,494 +$2,937,942 $33.49 89
2020 Q2 34,945,268 $824,517,432 +$9,797,711 $23.83 70
2020 Q1 34,562,212 $791,472,895 +$23,374,012 $22.90 67
2019 Q4 33,483,529 $948,191,901 +$22,388,802 $28.32 64
2019 Q3 15,935,472 $338,961,585 +$30,078,348 $21.49 52
2019 Q2 14,232,528 $409,341,450 +$409,341,450 $29.17 47